Maryland-based Novavax says protein vaccine works for children as young as 12 Novavax announced Thursday that its COVID-19 vaccine proved safe and effective in a study of 12- to 17-year-olds. innerharbor2022-02-11T00:38:21-05:00February 11th, 2022|